ArticleJournal of experimental orthopaedics2020

Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro.

Elisha Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.